|
- Cell painting Assay by Ncardia
Our work centers on a simple yet powerful premise: When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence
- iPSC-Based Assays | Ncardia
High-Throughput iPSC-Based Assays Integrating iPSC-based assays into large screening campaigns doesn’t have to be a challenge anymore Our team has the capabilities and expertise to: Miniaturize and reduce costs Automate relevant cell-based assays Keep a strong focus on delivering high-quality and reproducible data
- iPSC Technology by Ncardia
At Ncardia, we bring the expertise and capabilities to realize the full potential of iPSC solutions and facilitate their efficient and successful application in the discovery of new therapies for patients
- Discovery Services by Ncardia - Custom Disease Models
Our team has the capabilities and expertise to miniaturize - reducing costs - and automate relevant cell-based assays while keeping a strong focus on delivering high-quality and reproducible data
- Ncyte® vCardiomyocytes by Ncardia
Our work centers on a simple yet powerful premise: When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence
- Our Approach - Ncardia
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence
- About Us | Ncardia
Integrated iPSC-based drug discovery platform that allows pharmaceutical companies to mimic drug interactions with the human body from hit identification to lead optimization leveraging its large-scale manufacturing capabilities to ensure reproducible high-throughput screenings
- Case Study: Manufacturing iPSC-derived skeletal muscle cells
With the adequate expertise and capabilities, human iPSC technology can be used to bring human biology earlier in drug discovery to facilitate decision-making steps
|
|
|